HealthBlawg

David Harlow's Health Care Law Blog

  • About
  • Archives
  • Podcast
  • Press
  • Awards/Reviews
  • HIPAA
  • HCSM

FDA continues to detail types of mHealth apps it will not regulate

June 17, 2014

Since issuing its mobile medical applications guidance, the FDA has offered a number of clarifying statements, intended to give the regulated community a clearer idea of whether and when to expect any particular mHealth application to be considered a device.

Last week, the FDA added a category of applications with respect to which it intends to "exercise enforcement discretion" (i.e., not regulate):

  • Mobile apps that allows a user to collect, log, track and trend data such as blood glucose, blood pressure, heart rate, weight or other data from a device to eventually share with a heath care provider, or upload it to an online (cloud) database, personal or electronic health record. [Added June 11, 2014].

Other recent additions to the list include:

  • Mobile apps for providers that help track or manage patient immunizations by assessing the need for immunization, consent form, and immunization lot number [Added March 12, 2014];
  • Mobile apps that provide drug-drug interactions and relevant safety information (side effects, drug interactions, active ingredient) as a report based on demographic data (age, gender), clinical information (current diagnosis), and current medications [Added March 12, 2014];
  • Mobile apps that enable, during an encounter, a health care provider to access their patient’s personal health record (health information) that is either hosted on a web-based or other platform [Added March 12, 2014];

The more specific the FDA is willing to be, the better. Clarity is key for both the regulators and the regulated community. The FDA is apparently looking to greater self-regulation on the EHR front, and that sensibility seems to be rubbing off a bit here, too.

David Harlow
The Harlow Group LLC
Health Care Law and Consulting

Related Posts

  • FDA and Digital Health Regulation

    The FDA had a digital health banner day on December 7, announcing one final guidance…

  • Digital Health: Apps, Analytics & Agencies

    I spoke yesterday at the Massachusetts Bar Association's "Hot Topics in Healthcare" program. (Webcast live,…

  • Mobile Health Apps: Pass the Secret Sauce

    The IMS Institute for Healthcare Informatics released a report on the ecosystem bloody mess of 40,000+…

Filed Under: FDA, Health 2.0, Health care policy, Health Law, HIT, Medical Devices, mHealth, Mobile health

« Telehealth: Roy Schoenberg, CEO of American Well, Speaks with David Harlow
#FDAsm – FDA Releases Draft Social Media Guidance Five Years After Public Hearing »

Threads

Follow me on: Threads

Mastodon

Follow me on: Mastodon

HIPAAtools

Hipaatools

The HIPAA Compliance Toolkit

The Walking Gallery

The Walking Gallery

Quick Links

  • Home
  • Categories
  • Archives
  • Podcast Interviews
  • HIPAAtools
  • HIPAA Compliance
  • Health Care Social Media
  • Speaking
  • In the Press
  • Blogroll

David Harlow

David Harlow

HealthcareNOW Radio

  • Subscribe
  • Contact
  • Book Me: Speaking
  • About
  • The Harlow Group LLC
Copyright © 2006–2025
HealthBlawg is a publication of The Harlow Group LLC. See Copyright notice and disclaimer.
Fair use with attribution and a link is encouraged. Click for more on David Harlow.
[footer_backtotop text="Back to top" href="#"]